Published February 26, 2015
| Version v1
Journal article
Open
Evaluation of the Roche Cobas TaqScreen Multiplex V 2.0 Test for Blood Screening: A Saudi Arabian Study
Description
Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) strain variants, were investigated. The 95% LOD was employed in the experiment and the results returned a positive accuracy of 99.6%. which is consistent with the expected success rate as specified by Roche.
Read Complete Article at ijSciences: V4201501620